NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO)
INR 22.99
(1.37%)
INR 22.99
(1.37%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.13 Million | 5.49 Million | -1.1 Million | 1.98 Million | 2.4 Million | 205.07 Thousand |
| Net Income | 2.13 Million | 1.7 Million | 2.9 Million | 1.54 Million | -52.95 Million | -1.11 Million |
| Depreciation & Amortization | 18.92 Thousand | 13.72 Thousand | 27.4 Thousand | 26.2 Thousand | 26.23 Thousand | 26.24 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.07 Million | 3.19 Million | -5.01 Million | 255.9 Thousand | 1.66 Million | 1.25 Million |
| Other non-cash items | 4.43 Million | 9.69 Million | -3.65 Million | -4.03 Million | 50.7 Million | -942.1 Thousand |
| Investing Cash Flow | -29.95 Thousand | -63.39 Thousand | -11.4 Thousand | - | - | - |
| Investments in PPE | -29.95 Thousand | -63.39 Thousand | -11.4 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | -2.61 Million | 120 Thousand |
| Debt repayment | - | - | - | - | -2.61 Million | -120 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 240 Thousand |
| Accounts receivables | -7.09 Million | -433.02 Thousand | 1.21 Million | -1.21 Million | 429.86 Thousand | 545.41 Thousand |
| Accounts payables | 6.79 Million | -12.19 Million | 7.73 Million | 5.46 Million | 2.55 Million | 89.57 Thousand |
| Inventory | -3.31 Million | 3.54 Million | -4.25 Million | - | 21.79 Thousand | 398.85 Thousand |
| Other working capital | -3.46 Million | 12.27 Million | -9.7 Million | -3.99 Million | -1.34 Million | 220.14 Thousand |
| Cash at beginning of period | 3.51 Million | 1.07 Million | 2.19 Million | 209.19 Thousand | 416.66 Thousand | 91.59 Thousand |
| Cash at end of period | 2.34 Million | 3.51 Million | 1.07 Million | 2.19 Million | 209.19 Thousand | 416.66 Thousand |
| Capital Expenditure | -29.95 Thousand | -63.39 Thousand | -11.4 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.16 Million | 2.43 Million | -1.11 Million | 1.98 Million | -207.46 Thousand | 325.07 Thousand |
| Free Cash Flow | -4.16 Million | 5.43 Million | -1.11 Million | 1.98 Million | 2.4 Million | 205.07 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.13 Million | 466 Thousand | 815 Thousand | 269 Thousand | 1.7 Million | -1 Million |
| Depreciation & Amortization | 18.92 Thousand | 6000.00 | 4000.00 | 4000.00 | 13.72 Thousand | 3000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.07 Million | - | - | - | 3.19 Million | - |
| Other non-cash items | 4.43 Million | -6000.00 | -4000.00 | -4000.00 | 9.69 Million | -3000.00 |
| Investing Cash Flow | -29.95 Thousand | - | - | - | -63.39 Thousand | - |
| Investments in PPE | -29.95 Thousand | - | - | - | -63.39 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -7.09 Million | - | - | - | -433.02 Thousand | - |
| Accounts payables | 6.79 Million | - | - | - | -12.19 Million | - |
| Inventory | -3.31 Million | - | - | - | 3.54 Million | - |
| Other working capital | -3.46 Million | - | - | - | 12.27 Million | - |
| Cash at beginning of period | 3.51 Million | 6.61 Million | 5.8 Million | 3.51 Million | 1.07 Million | 4.51 Million |
| Cash at end of period | 2.34 Million | 466 Thousand | 6.61 Million | 269 Thousand | 3.51 Million | 3.51 Million |
| Capital Expenditure | -29.95 Thousand | - | - | - | -63.39 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.16 Million | -6.15 Million | 815 Thousand | -3.24 Million | 2.43 Million | -1 Million |
| Free Cash Flow | -4.16 Million | 466 Thousand | 815 Thousand | 269 Thousand | 5.43 Million | -1 Million |
HHSRF
300776
EMPOWER
WBUY
ALWF
DTSS